Financials
- Market Capitalization 3.09 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-20.4
Relación precio/flujo de caja
184.61
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1689 | IMNM Immunome, Inc. - Common Stock | 27.56 USD | -4.54% | -3.37% | +18.38% | +178.67% | 3.13 B USD | ||
| 1692 | CLDX Celldex Therapeutics, Inc. - Common Stock | 39.10 USD | -3.36% | -3.17% | +9.89% | +43.54% | 3.07 B USD | ||
| 1704 | IRON Disc Medicine, Inc. - Common Stock | 80.04 USD | -3.04% | +0.29% | +7.49% | +33.73% | 3.07 B USD | ||
| 1719 | BEAM Beam Therapeutics Inc. - Common Stock | 29.29 USD | -3.90% | -1.58% | +11.84% | +73.62% | 3.03 B USD |